C13 - UREA
Country: Iżrael
Lingwa: Ingliż
Sors: Ministry of Health
Fuljett ta 'informazzjoni
(PIL)
21-12-2021
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
UREA- C 13
Disponibbli minn:
MERIDIAN BIOSCIENCE ISREAL LTD., ISRAEL
Għamla farmaċewtika:
TABLETS
Kompożizzjoni:
UREA- C 13 75 MG
Rotta amministrattiva:
PER OS
Tip ta 'preskrizzjoni:
Required
Manifatturat minn:
MERIDIAN BIOSCIENCE ISREAL LTD., ISRAEL
Indikazzjonijiet terapewtiċi:
Intended for use in the qualitative detection of urease associated with H. Pylory in the human stomach and as an aid in the initial diagnosis and post treatment monitoring of H. Pylory infection in adult patients.
Data ta 'l-awtorizzazzjoni:
2015-02-28
Fuljett ta 'informazzjoni
ةحصلا ةرازو تاداشرلإ ا
ً
قفو 2021 سطسغأ يف ثيدحتلا مت
،.ض.م ليئارسإ سنيياسويب لاوزلا طخ
:ليجستلا بحاصو جتنملا
.ليئارسا ، 7177872 نيعيدوم ،4 نايعمه عراش
COMPOSITION:
Revised in September 2021 according to MoH guidelines.
MANUFACTURER AND REGISTRATION HOLDER: Meridian Bioscience
Israel Ltd., 4 Hamaayan St. Modiin 7177872
LB00064 REV.04
Aqra d-dokument sħiħ
